The European Medicines Agency said on Thursday it recommends the use of Pfizer – BioNTech’s Covid-19 vaccine for children aged 5 to 11, paving the way for an EU-wide shot to be authorized in the coming days .
The EMA said the vaccine was used from adults to adolescents in May, and the dose used on young children would be reduced to a third of the dose used on adults. in a release,
The most common side effects in children aged 5 to 11 are similar to those seen in older patients and “usually are mild or moderate and improve within a few days of vaccination,” the EMA said.
Final approval must now come from the European Commission – the EU’s executive body. It usually follows the recommendation of the drug regulator and may make its decision public by Friday. However, shots for this age range won’t be expected to begin until next month, when a lower-dose version is available.
The EMA’s recommendation comes as the virus continues to spread again in Europe, making the continent the epicenter of the pandemic again, which is on track to hit. 2 million deaths According to the World Health Organization, by March next year.